股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 雍禾醫療集團有限公司 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02279 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | USD | | 0.0000025 USD | | 50,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 20,000,000,000 | USD | | 0.0000025 USD | | 50,000 | 本月底法定/註冊股本總額： USD 50,000 ...

Group 1 - The core theme of the forum was "ESG Practice and Value Creation," attracting over a hundred executives and industry experts to discuss the evolution of ESG standards and their impact on long-term corporate value [4] - Yonghe Medical was awarded the "Corporate Governance Pioneer Award" for its commitment to standardized operations and robust governance, highlighting its leadership in the hair medical service sector in China [4][6] - The company has implemented a refined operational strategy, enhancing its self-developed chain medical management system "Hefan" with AI knowledge integration, leading to improved governance and operational efficiency [4][6] Group 2 - Yonghe Medical's half-year performance forecast for 2025 indicates a net profit of no less than RMB 25 million, a significant turnaround from a loss of RMB 138.6 million in the same period of 2024, with an expected gross margin increase of 4.5 to 5.5 percentage points [4][6] - The company actively engages in sustainable development through initiatives like the "Hair Forest Public Welfare Plan," which aims to combat desertification by planting trees in arid regions of China [6][8] - The "Let Beauty Grow" initiative provides free hair restoration services to 100 social guardians, including firefighters and healthcare workers, and the company has donated high-quality wigs valued at RMB 560,000 to cancer patients experiencing hair loss due to treatment [8] Group 3 - The ESG Annual Forum has become a significant platform for promoting ESG ecosystem development in China since its inception in 2023, with Yonghe Medical's recognition underscoring its commitment to ESG governance and its role as a leader in the hair medical industry [8] - The hair medical industry is transitioning from "high-speed growth" to "high-quality growth," with ESG practices increasingly recognized as a key driver for long-term value creation in healthcare enterprises [8] - Yonghe Medical aims to deepen its ESG practices and explore governance-driven long-term value creation, responding to societal concerns and establishing itself as a trusted entity in the hair health ecosystem [8]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 1 (i) 本集團通過優化門店網絡佈局，有效將資源聚焦核心門店，顯著提升院部運 營效率；此外，持續升級自研連鎖醫療管理系統「禾帆」，融入企業AI知識庫 引擎並形成智能化解決方案。上述舉措幫助本集團實現對其主營業務增效、 質控、降本的精細化管理，帶動毛利率顯著增長。預計於有關期間，本集團 毛利率增長4.5至5.5個百分點。 (ii) 本集團通過管理模型重構及營銷投放精細化管理，顯著提升獲客轉化率及投 入產出比；同時進行組織架構調整，提升人力資源配置效率，進一步優化 成本結構。預計於有關期間，銷售費用率和管理費用率※將分別下降6.0%至 8.0%以及2.0%至3.0%。這一系列舉措亦為本公司實現扭虧為盈以及未來長期 可持續盈利奠定堅實基礎。 截至本公告日期，本公司現正落實本集團於有關期間的中期業績。本公告所載資 料僅為根據本集團未經審核合併管理賬目及於本公告日期董事會目前可得資料而 作出的初步審閱，該等資料 ...

资料显示，雍禾医疗集团有限公司是一家提供一站式毛发医疗服务的医疗集团,自2005年开始,公司一直 专注于毛发医疗服务市场,并构建了以"雍禾医疗"为核心,由专业植发品牌"雍禾植发"、医疗养固品牌"史 云逊"、女性美学植发品牌"雍禾发之初"及医学假发品牌"哈发达"等组成的全产业链品牌矩阵。经过十 多年的发展,截止2023年6月30日,公司已在中国68个城市拥有72家植发医疗机构。利用标准、成熟的医生 培养体系,如今公司已建立一支一千六百余人的专业医疗团队,其中包括三百余名注册医生及一千余名护 士。目前公司已成为中国植发医疗及医疗养固服务市场的重要品牌。 （以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。） 来源：金融界 机构评级方面，目前暂无机构对该股做出投资评级建议。 行业估值方面，医疗保健设备和服务行业市盈率（TTM）平均值为-2.12倍，行业中值0.38倍。雍禾医疗 市盈率-6.77倍，行业排名第88位；其他巨星医疗控股（02393.HK）为0.37倍、京玖康疗（00648.HK） 为0.38倍、医汇集团（08161.HK）为2.35倍、瑞慈医疗（01526.HK）为5.45倍 ...

Group 1: Market Trends - The paper sector continues its upward trend, with Nine Dragons Paper (02689.HK) leading the gains, rising over 9% after announcing a price increase of 30 CNY/ton for corrugated paper and recycled cardboard starting August 1, reflecting an optimized supply-demand structure in the industry [1] - The brokerage sector saw collective strength, with major Chinese brokerages like Dongfang Securities (03958.HK) and Zhongyuan Securities (01375.HK) rising over 6% and 5% respectively, indicating significant capital inflow into the sector [1] - Urban Beauty (02298.HK) surged 13% as its online GMV for 2024 is projected to reach 1.57 billion CNY, marking a 100% year-on-year increase, showcasing the effectiveness of its new retail transformation [1] Group 2: Company Performance - China Duty Free Group (01880.HK) soared 17% after Macquarie's report indicated a narrowing year-on-year revenue decline from 19.5% in Q4 2024 to 11% in Q1 2025, with a stable gross margin of 33% [1] - The gaming sector experienced a broad increase, with companies like 澳博控股 (00880.HK) and 银河娱乐 (00027.HK) rising over 3%, supported by UBS data showing Macau's average daily gaming revenue in July at 683 million MOP, a 14% year-on-year increase [2] - 雍禾医疗 (02279.HK) saw a 13% increase after forming a strategic partnership with Meituan Health to build a medical-grade hair health service system [2] Group 3: Real Estate and Financing - The Hong Kong real estate sector collectively strengthened, with Country Garden (02007.HK) leading with nearly a 10% rise, driven by improved financing conditions as indicated by the People's Bank of China's report showing a recovery in real estate loan growth [3] - Meilan Airport (0357.HK) rose 10% as CITIC Securities highlighted the significance of Hainan's trade opening, which is expected to benefit the local tourism industry [3] Group 4: Gold Sector Decline - The gold sector faced pressure, with companies like 潼关黄金 (00340.HK) and 大唐黄金 (08331.HK) dropping over 4%, attributed to a decline in spot gold prices below 3,380 USD/oz, driven by reduced safe-haven appeal due to easing trade tensions [4] Group 5: US Market Highlights - Futu Holdings (FUTU.US) rose 2.82% after announcing a long-term strategic partnership with Huaxia Fund to promote the integration of traditional finance and blockchain technology [5] - Japanese automotive stocks surged, with Toyota (TM.US) and Honda (HMC.US) rising over 13% following news of a trade agreement reducing tariffs on Japanese cars [6] - Nuclear power stocks in the US saw significant gains, with Oklo Inc (OKLO.US) rising 9.21%, reflecting a growing interest in nuclear energy [5]

Core Viewpoint - The establishment of the Hair Medicine Professional Committee marks a significant step towards standardization in China's hair medical industry, which is experiencing rapid growth and is expected to reach a market size of 138.1 billion yuan by 2030 with a compound annual growth rate of 22.3% over the next decade [3][4]. Group 1: Industry Development - The hair medical industry in China is transitioning from "high-speed growth" to "high-quality development," necessitating the establishment of industry rules and talent standards [5][6]. - The Hair Medicine Professional Committee aims to address the gaps in talent, technology, and standard systems that currently exist in the rapidly expanding market [4][6]. Group 2: Committee Initiatives - The committee will focus on developing industry standards, professional training, technical certification, and member recruitment [7]. - The committee's formation is supported by various experts from medical, pharmaceutical, and academic fields, who emphasize the need for a systematic support framework beyond just technology and marketing [6][7]. Group 3: Company Contributions - Yonghe Medical, a leading player in the hair medical sector with 20 years of experience, is a key initiator of the committee and has already established a multi-layered capability system in hair diagnosis, treatment, and doctor training [5][7]. - The company promotes a "good doctor, one case per person" philosophy in medical quality management and emphasizes a dual focus on medical skills and aesthetics in training [7].

Group 1 - The core event was the "2025 High-Quality Consumer Brand TOP 100 Innovation Ecosystem Conference" held in Shanghai, where Yonghe Medical was recognized as one of the "Top Ten Consumer Technology Innovation Brands" for its continuous investment and innovation in AI service systems and digital transformation in hair health [1][3]. - The award was initiated by Southern Metropolis Daily in collaboration with multiple organizations, focusing on five dimensions: brand influence, innovation, social responsibility, enterprise scale, and market potential, to identify innovative forces driving consumption upgrades [3]. - AI application upgrades emerged as a key theme at the conference, with various brands from sectors such as beauty, healthcare, home, apparel, and retail showcasing their collective innovations in smart manufacturing and user operations [3]. Group 2 - Yonghe Medical is leveraging AI technology to reconstruct service models and enhance user experience in the hair health sector, becoming one of the most digitized companies in this field [3][4]. - The company has developed an "AI Hair Health Self-Test Mini Program" that uses image recognition and hair loss assessment models to provide users with personalized treatment suggestions based on uploaded photos [3][4]. - Yonghe Medical is also advancing "hair loss gene testing" in collaboration with Sun Yat-sen University to create predictive models for individual risk assessment and personalized prevention strategies [4]. Group 3 - Yonghe Medical has been in the hair medical field for nearly 20 years, offering a comprehensive range of services and has established a brand matrix that includes various specialized brands [4]. - According to the "2023 China Hair Health Lifestyle Blue Book," Yonghe Medical ranks first in market size, female selection rate, brand awareness, user satisfaction, and recommendation rate within the industry [6]. - The company plans to continue enhancing AI's role in hair health management and expand its smart products and services to create a user-centered one-stop hair health management service [7].

Company Overview - Yonghe Medical Group Limited is a medical group providing one-stop hair medical services, focusing on the hair medical service market since 2005 [3] - The company has established a brand matrix including "Yonghe Medical," "Yonghe Hair Transplant," "Shiyunxun," "Yonghe Fazhichu," and "Hafada" [3] - As of June 30, 2023, the company operates 72 hair transplant medical institutions across 68 cities in China [3] - The company has built a professional medical team of over 1,600 members, including more than 300 registered doctors and over 1,000 nurses [3] Financial Performance - For the fiscal year ending December 31, 2024, Yonghe Medical reported total revenue of 1.804 billion yuan, a year-on-year increase of 1.53% [2] - The company recorded a net profit attributable to shareholders of -226 million yuan, showing a significant year-on-year increase of 58.58% [2] - The gross profit margin stands at 60.08%, while the debt-to-asset ratio is 58.65% [2] Stock Performance - Over the past month, Yonghe Medical's stock has increased by 73.45%, and year-to-date, it has risen by 117.78%, outperforming the Hang Seng Index's increase of 19.1% [2] - As of the latest trading session, the stock price was 2.22 HKD per share, reflecting a 13.27% increase with a trading volume of 3.186 million shares and a turnover of 6.9939 million HKD [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -2.53 times, with a median of 0.38 times [3] - Yonghe Medical's P/E ratio is -4.21 times, ranking 89th in the industry [3] - Comparatively, other companies in the sector have P/E ratios such as Giant Star Medical Holdings at 0.28 times, Jingjiu Kangliao at 0.38 times, and others ranging up to 5.35 times [3]

雍禾醫療集團有限公司（「本公司」）於2025年6月20日舉行之股東週年大會（「股東 週年大會」）上，所有列載於日期為2025年4月30日之股東週年大會通告內的建議 決議案均以一股一票方式進行投票表決。投票表決結果如下： | | 普通決議案 | | 有效投票票數(%) | | --- | --- | --- | --- | | | | 贊成 | 反對 | | 1. | 接收、考慮及採納截至2024年12月31日止年度 | 290,436,916 | 962,400 | | | 的本公司經審核合併財務報表、本公司董事會 | (99.67%) | (0.33%) | | | （「董事會」）報告及核數師報告。 | | | | 2. | 重選張輝先生為本公司執行董事。 | 290,436,916 | 962,400 | | | | (99.67%) | (0.33%) | | 3. | 重選韓志梅女士為本公司執行董事。 | 290,436,916 | 962,400 | | | | (99.67%) | (0.33%) | | 4. | 重選耿嘉琦先生為本公司非執行董事。 | 290,436,916 | 962,400 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 雍禾醫療集團有限公司 呈交日期： 2025年6月5日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02279 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫 ...